What is the us filing date for apotex's ruxolitinib generic?

What is Apotex’s US filing date for its ruxolitinib generic?

The provided information does not include Apotex’s US filing date for a ruxolitinib generic, so I can’t state the date from the given context.

Where to find the exact filing date (and what it usually refers to)

For US generic approvals, the “filing date” is typically the submission date of the Abbreviated New Drug Application (ANDA) with the FDA (or the date a related patent/Orange Book entry was tied to the application). The exact date can be pulled from FDA/ANDA records or Orange Book listings, depending on how “filing date” is being defined.

If you share one detail, I can pinpoint the date

If you tell me the specific product/application identifier you mean (for example, the ANDA number or the exact NDA/brand name listing it matches, such as Jakafi/generic ruxolitinib), I can help identify the correct “US filing date” format that applies to it and report the date precisely.